Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2012
07/05/2012WO2012061820A9 Materials and methods for treating radiation poisoning
07/05/2012WO2012055567A3 Use of malononitrilamides in neuropathic pain
07/05/2012WO2012053827A9 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
07/05/2012WO2012048125A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
07/05/2012WO2012045083A9 Minimizing intestinal dysfunction
07/05/2012WO2012031220A3 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012WO2012026771A3 Composition comprising wercklea insignis extracts and fractions thereof for preventing and treating inflammatory diseases or asthma
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172449 Polyamine transport inhibitors as novel therapeutics
07/05/2012US20120172446 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
07/05/2012US20120172438 Glycyrrhetinic acid ester derivative synthesis method and deoxoglycyrrhetinic acid ester compound
07/05/2012US20120172431 Omega 3 fatty acid formulations
07/05/2012US20120172429 Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
07/05/2012US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability
07/05/2012US20120172421 2, 6 xylidine derivatives for the treatment of pain
07/05/2012US20120172420 Method for Modulating Responsiveness to Steroids
07/05/2012US20120172416 Method for the preparation of micro-rna and its therapeutic application
07/05/2012US20120172410 Short hairpin rna for gene knockdown of nr1 subunit of the n-methyl-d-aspartate receptor and its application on pharmaceutics
07/05/2012US20120172408 Active ingredient comprising indocyanine green and/or infracyanine green
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172398 Co-crystals of tramadol and coxibs
07/05/2012US20120172394 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172392 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (ssao) enzyme activity and vap-1 mediated adhesion useful for treatment of diseases
07/05/2012US20120172389 Treatment of fibrosing disorders
07/05/2012US20120172385 Ortho substituted pyrimidine compounds as jak inhibitors
07/05/2012US20120172384 Heterocyclylaminopyrimidines as kinase inhibitors
07/05/2012US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172366 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172354 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172347 8-oxodihydropurine derivative
07/05/2012US20120172345 Heteroaryls and uses thereof
07/05/2012US20120172341 Compositions comprising tramadol and celecoxib in the treatment of pain
07/05/2012US20120172339 Angiogenic resorcinol derivatives
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120172330 Human milk oligosaccharides for modulating inflammation
07/05/2012US20120172329 Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
07/05/2012US20120172328 Hyaluronic acid-based gels including lidocaine
07/05/2012US20120172327 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
07/05/2012US20120172325 Methods and Compositions for the Treatment of Gastrointestinal Disorders
07/05/2012US20120172324 Compositions and methods for reducing the risk of agent-induced liver toxicity
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120171297 Threo-dops controlled release formulation
07/05/2012US20120171296 Rapidly disintegrating solid preparation
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171281 Novel Formulations of Volatile Anesthetics and Methods of Use for Reducing Inflammation
07/05/2012US20120171278 Percutaneous absorption type plaster
07/05/2012US20120171275 Local administration of gallium compositions to treat pain
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171207 Depleting immunosuppressive monocytes within a mammal
07/05/2012US20120171203 Activin receptor-like kinase-1 compositions and methods of use
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/05/2012US20120171198 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and manifestations via the mucosal route
07/05/2012US20120171197 Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/05/2012US20120171180 Compositions comprising amnion derived adherent cells and platelet-rich plasma
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171168 Method for treating pancreatitis with mesenchymal stem cells
07/05/2012US20120171159 Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171116 Arginase Inhibitors and Methods of Use Thereof
07/05/2012US20120168335 Fast Disintegrating Compositions of Meloxicam, Processes for Preparation, and Use to Treat Arthritis and/or Pain
07/05/2012CA2822500A1 Human milk oligosaccharides to promote growth of beneficial bacteria
07/05/2012CA2822490A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/05/2012CA2818468A1 Treatment of pain associated with dislocation of basal endometrium
07/04/2012EP2471803A1 Compounds that interact with kinases
07/04/2012EP2471802A1 Phosphoramidates of monosaccharides
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471537A1 Treatment of pain associated with dislocation of basal endometrium
07/04/2012EP2471536A1 Steroid analogs and characterization and treatment methods
07/04/2012EP2470909A2 Adam12 inhibitors and their use against inflammation-induced fibrosis
07/04/2012EP2470671A1 Antikine antibodies that bind to multiple cc chemokines
07/04/2012EP2470524A1 Pyrrolidine derivatives as nk3 receptor antagonists
07/04/2012EP2470508A1 Cannabinoid receptor modulators
07/04/2012EP2470506A1 Kinase inhibitors
07/04/2012EP2470270A1 Compounds for treatment of inflammation
07/04/2012EP2470185A1 Pharmaceutical compositions for treating ibd
07/04/2012EP2229150B1 Systems and methods for delivery of materials
07/04/2012EP2178888B1 Proteasome inhibitors
07/04/2012EP2120950B1 Use of quinoline derivatives in the treatment of pain
07/04/2012EP2004649B1 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
07/04/2012CN202288921U Compound naproxen esomeprazole tablet
07/04/2012CN1977043B Natural IgM antibodies and inhibitors thereof
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1272